Background/Aims: The transcription factor CCAAT/enhancer-binding protein α (C/EBPα) is a basic leucine zipper transcription factor that plays essential roles in tumor progression. Although decreased or absent C/EBPα expression in many cancers suggests a possible role for C/EBPα as a tumor suppressor, the functions of C/EBPα in lung adenocarcinoma remain unclear. Methods: Here, C/EBPα expression levels in 26 lung adenocarcinoma and para-carcinoma tissue samples were detected by qRT-PCR and immunohistochemistry. Cell transwell assays, wound healing assay and three-dimensional spheroid invasion assay were performed to assess the effects of C/EBPα on migration and invasion in lung adenocarcinoma cells in vitro.
Introduction
Lung cancer is one of the leading types of cancer-related mortality worldwide, responsible for nearly 1.4 million deaths each year [1, 2] . Non-small-cell lung cancer (NSCLC) is the main histological category of lung cancer, accounting for 75-80% of all cases, and lung adenocarcinoma is one of the most common subtypes [3] . More than 50% of NSCLC patients reveal local invasion or distant metastasis when diagnosed [4, 5] . Thus, early diagnosis of NSCLC is very difficult for the majority of patients diagnosed at an advanced stage [6] . Novel insights into the regulatory mechanisms underlying NSCLC pathogenesis are critically needed.
CCAAT/enhancer-binding protein-α (C/EBPα) is a transcription factor that plays important roles in the regulation of cell proliferation and differentiation [7] [8] [9] [10] [11] . As a tumor suppressor, C/EBPα was found to be downregulated in several types of cancer and regulated cancer cell behaviors such as proliferation, differentiation and metabolism [12, 13] . In the lung, C/EBPα is highly expressed in alveolar type II cells, Clara cells, and alveolar macrophages [14, 15] . Low expression levels of C/EBPα were found in 50% of stage II and IIIA lung adenocarcinomas, and induction of C/EBPα led to significant growth reduction attributable to proliferation arrest, morphological changes characteristic of differentiation and apoptosis [16] [17] [18] . A recent study also showed that C/EBPα was a tumor suppressor in lung cancer and that targeted B lymphoma Mo-MLV insertion region 1 homolog (BMI1) inhibition impaired tumor growth in lung adenocarcinomas with low C/EBPα expression [19] . C/ EBP family members also regulate cell migration [20] . With regard to lung adenocarcinoma cell migration and invasion, the precise function of C/EBPα and its underlying mechanism remain unclear.
In the present study, we identified significant downregulation of C/EBPα in lung adenocarcinoma tissues. Overexpression of C/EBPα strikingly suppressed the invasion and migration of lung adenocarcinoma cells. Importantly, these functional effects of C/EBPα were exerted by suppressing β-catenin-mediated the epithelial-mesenchymal transition (EMT). Thus, our findings provide a novel mechanistic role for C/EBPα in lung adenocarcinoma metastasis and a rationale for clinically exploring the use of this molecule in curbing lung adenocarcinoma aggressiveness.
Materials and Methods

Tissue samples and cell cultures
Matched pairs of lung adenocarcinoma and para-carcinoma tissue used in the study were obtained from 26 patients at Qingpu Branch Zhongshan Hospital (Shanghai, China). The tissues were stored in liquid nitrogen. Informed consent was obtained from each patient who underwent lung cancer radical resection prior to surgery and this study was conducted in accordance with a protocol approved by the Ethics Committee of Fudan University (Shanghai, China). Human lung adenocarcinoma cell lines were purchased from Cell Bank of Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China) and cultured in RPMI-1640 medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum, 100 U/ mL of penicillin and 100 μg/mL of streptomycin. Both cell lines were maintained at 37°C in a humidified atmosphere of 5% CO 2 .
RNA isolation and qRT-PCR
Total RNA was prepared from tissues or cells using TRIzol reagent (TaKaRa, Dalian, China). cDNA was synthesized using a PrimeScript RT Reagent Kit (TaKaRa) according to the manufacturer's instructions. Quantitative real-time PCR was carried out using SYBR Premix Ex Taq (TaKaRa) to determine the expression level of gene transcripts for C/EBPα, E-cadherin, N-cadherin, vimentin, β-catenin, cyclin D1, c-myc and β-actin. The sequences of real-time PCR primers were as follows:
C/EBPα forward 5′-ATCTGCGAGCACGAGACGTCCAT-3′; reverse 5′-CAGCTGCTTGGCTTCATCCTCCT-3′; E-cadherin forward 5′-GGACAGCCTATTTTTCCCTCGAC-3′; reverse 5′-ACCCAGTCTCTCTTCTGTCTT-CT-3′; N-cadherin forward 5′-ATCCCTCCAATCAACTTGCCAGA-3′; reverse 5′-CCCATTCCAAACCTGGTGTAA-GA-3′; vimentin forward 5′-CAGGACTCGGTGGACTTCTCGCT-3′; reverse 5′-TTCTCCCGGAGGCGCAT-GATGTC-3′; β-catenin forward 5′-TGGGAACAGGGATTTTCTCAGTC-3′; reverse 5′-TGGTCCTCGTCATT-TAGCAGTTT-3′; cyclin D1 forward 5′-TACCCCGATGCCAACCTCCTCAA-3′; reverse 5′-TTAGAGGCCACGAACAT-GCAAGT-3′; c-myc forward 5′-GACTCGGTGCAGCCGTATTTCTA-3′; reverse 5′-GAAGCCGCTCCACATACAGTCCT-3′; β-actin forward 5′-ATCCAGGCTGTGCTGTCCCCGTA-3′; reverse 5′-GAAGTCCAGGGCAACATAGCACA-3′; The relative fold change in gene expression normalized to the housekeeping gene β-actin was calculated by the 2− ΔΔCt method.
Lentiviral infection
C/EBPα sequences were amplified and cloned into the lentiviral vector pCDH-CMV-MCS-EF1-copG-FP (System Biosciences, Mountain View, CA, USA). The empty backbone vector was used as a control. The constructs were co-transfected with packing plasmids into 293T packing cells using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA). Virus particles were harvested 48 h after transfection. A549 and H1299 cells were infected with recombinant lentivirus-transducing units in the presence of 5 mg/ml polybrene (Sigma-Aldrich, St Louis, MO, USA).
Transwell invasion and migration assays
Cell migration and invasion were measured using 24-well Transwell plate cell culture inserts (Corning, Cambridge, MA, USA) with or without Matrigel coating (BD Biosciences, San Jose, CA, USA). In brief, 1 × 10 5 infected A549 or H1299 cells in serum-free RPMI-1640 medium were placed in the upper chamber of each insert, and medium containing 10% fetal bovine serum was added to the lower chamber. After 24 h incubation, the cells remaining on the upper surface of the membranes were removed, and cells that had migrated to or invaded the lower surface were fixed, stained and counted under an inverted microscope (×200) to calculate their relative numbers. All assays were performed in triplicate.
Wound healing assay
Infected A549 and H1299 cells were seeded into six-well plates and cultured until totally confluent. Cells were then starved overnight in serum-free RPMI-1640 medium. Artificial wounds were created by a sterile 200 µl pipette tip, and the cells were washed with serum-free medium to remove floating cells and debris. Images were taken at 0 and 24 h on a microscope (Olympus Corp., Tokyo, Japan). Migration ability was assessed by measuring changes in the size of the wounded areas. Cells (2 × 10 3 ) were mixed with 20% Matrigel and seeded in 24-well plates coated with 100% Matrigel (BD Biosciences), and medium was changed every other day. Five days after plating, 10 μg/mL mitomycin C (Sigma-Aldrich) was added to the medium to block proliferation for another five days. Tumor cell outgrowth was visualized by microscopy.
Three-dimensional spheroid invasion assay
Western blotting
Cell proteins were isolated using RIPA buffer supplemented with protease and phosphatase inhibitors (Applygen Technologies Inc., Beijing, China), and quantified by a BCA protein assay kit (Beyotime Institute of Biotechnology, Jiangsu, China). Equivalent amounts of protein were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA), which were then blocked in 5% nonfat dried milk for 1 h at room temperature and incubated overnight at 4°C with primary antibodies obtained from Cell Signaling Technology (Danvers, MA, USA) against C/EBPα (#8178), E-cadherin (#14472), N-cadherin (#13116), vimentin (#5741), β-catenin (#8480), c-myc (#5605,) and cyclin D1 (#2978). Antiserum against β-actin was obtained from Santa Cruz Biotechnology (sc-47778; Santa Cruz, CA, USA). All antisera were used at a working dilution of 1:1000. Membranes were then incubated with horseradish peroxidase (HRP)-labeled secondary antibody and the bands were detected using an enhanced chemiluminescence kit (Pierce, Rockford, IL, USA).
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Immunohistochemistry (IHC) analysis
IHC was performed as previously described [21] . Briefly, tissues were fixed in phosphate-buffered neutral formalin, embedded in paraffin and cut into 5 µm-thick sections. Tissue sections were deparaffinized, rehydrated, and microwave-heated in sodium citrate buffer for antigen retrieval. The sections were then incubated overnight at 4°C with a 1:200 dilution of primary antibody against C/EBPα (#8178, Cell Signaling Technology). After washing in PBS, detection of the primary antibody was performed using goat anti-rabbit HRP-conjugated secondary antibody for 1 h at room temperature. Immunolabeling was visualized with 3, 3-diaminobenzidine tetrahydrochloride, followed by counterstaining with hematoxylin.
Luciferase reporter assay
Luciferase reporter assay was performed as previously described [22] . Briefly, cells were seeded on 24-well culture plates and grown overnight. Cells were transiently transfected with TOPflash or FOPflash (Upstate, Lake Placid, NY, USA) along with pRL-TK (Promega, Madison, WI, USA) using GeneJuice™ transfection reagent (Novagen, Madison, WI, USA). After 48 h incubation, cells were washed twice with PBS, lysed with Passive Lysis Buffer and Dual-Luciferase reporter assays (Promega) were performed as per the manufacturer's instructions. Firefly (TOPflash or FOPflash) and Renilla (pRL-TK) luciferase activities were measured in the lysates using a Centro LB 960 Microplate Luminometer (Berthold Technologies, Oak Ridge, TN, USA). Firefly luciferase values were normalized to Renilla luciferase values to control for transfection efficiency.
Statistical analysis
All statistical analyses were carried out using SPSS 17.0 (Chicago, IL, USA). Student's t-test was used to compare data from two groups represented as means±SD. Differences were considered significant at values of P < 0.05.
Results
The expression of C/EBPα is downregulated in lung adenocarcinoma cells and tissues
To explore the expression and significance of C/EBPα in lung adenocarcinoma, we measured C/EBPα expression in 26 lung adenocarcinoma and para-carcinoma tissue samples by qRT-PCR and IHC. qRT-PCR analysis showed that C/EBPα expression was significantly lower in lung adenocarcinoma tissues than in para-carcinoma tissues (Fig. 1A) . In addition, C/EBPα protein was expressed at a much lower level in lung adenocarcinoma tissues by IHC (Fig. 1B) . These experimental results showed that C/EBPα expression was decreased in cancerous tissue and thus may be an important factor that could inhibit lung adenocarcinoma. 
C/EBPα inhibits lung adenocarcinoma cell migration and invasion ability
To explore the biological function of C/EBPα in lung adenocarcinoma cells, Transwell assays and wound-healing migration assays were performed. An equal number of A549 and H1299 cells infected with a C/EBPα-overexpressing lentivirus or control lentivirus were plated. Overexpression of C/EBPα suppressed the migration and invasion of A549 and H1299 cells and resulted in a reduction of the number of invasive or migratory cells compared to the control group, as examined in Transwell migration and Matrigel invasion assays, respectively ( Fig. 2A-D) . Similar to its effect on cell motility in the wound-healing assay (Fig. 2E-F) , C/EBPα overexpression reduced the distances migrated by A549 and H1299 cells 24 h after transfection. Furthermore, we found that the invasive capacity of C/EBPα-transfected cells was significantly impaired in 3-dimensional spheroid invasion assay (Fig. 2G) . Taken together, these results strongly suggest that C/EBPα significantly decreases the migration and invasion ability of lung adenocarcinoma cells in vitro. 
Overexpression of C/EBPα in lung adenocarcinoma cell lines inhibits cell migration and invasion by suppressing EMT
EMT is a key event in the invasion and metastasis of tumors [23] . Therefore, we examined whether overexpression of C/EBPα in A549 and H1299 cells affected EMT. The results indicated that overexpression of C/EBPα increased expression of the epithelial marker E-cadherin and decreased expression of the mesenchymal markers N-cadherin and vimentin (Fig. 3A) . Similar results were observed in qRT-PCR analysis showing that upregulation of C/EBPα elevated mRNA expression of E-cadherin and diminished expression of N-cadherin and vimentin mRNA in A549 and H1299 cells (Fig. 3B) . These findings suggest that C/EBPα overexpression may prevent the migration and invasion of lung adenocarcinoma cells by inhibiting EMT.
C/EBPα suppresses the transcription of β-catenin
To further examine how C/EBPα is involved in cell migration and invasion signaling pathways, luciferase assays were performed using TOP Flash reporter plasmids. The TOP Flash reporter contains TCF-binding sites upstream of the luciferase gene and is a reporter of β-catenin/TCF/LEF complex transcription activity. The luciferase activity of the TOP Flash reporter was significantly decreased by the upregulation of C/EBPα (Fig. 4A ). This result indicates that inhibition of cell invasion and migration by C/EBPα is mediated by the β-catenin/TCF/LEF signaling pathway. Hence, we used western blotting to measure the protein expression level of β-catenin in the C/EBPα-upregulated cells. β-catenin protein expression was significantly decreased in C/EBPα-upregulated A549 and H1299 cells, with a simultaneous decrease in the levels of c-myc and cyclin D1, which are the downstream targets of β-catenin (Fig. 4B) . In contrast with the control group, the mRNA level of β-catenin was also decreased in C/EBPα-upregulated A549 and H1299 cells (Fig. 4C) .
To further confirm the correlation of C/EBPα and β-catenin in vivo, we used qRT-PCR to measure the expression levels of β-catenin mRNA in the same 26 pairs of human lung adenocarcinoma tissues and adjacent non-cancerous tissues that we had initially measured C/EBPα mRNA expression levels in, as described above. The β-catenin mRNA expression level was significantly greater in the cancerous tissue than in the non-cancerous tissue (Fig.  4D) . The association of C/EBPα and β-catenin mRNA expression was then analyzed by Pearson's correlation test, which showed a significant negative correlation between the mRNA expression levels of these two transcripts (Fig. 4E) . Together, these results strongly suggest that C/EBPα inhibits the transcription of β-catenin.
Discussion
Although a decrease or the complete absence of C/EBPα has been associated with poor prognosis and metastasis in a multitude of human tumors [18, 24] , the functions of C/EBPα in lung adenocarcinoma remain unclear. In this study, we revealed the critical role of C/EBPα in lung adenocarcinoma and its underlying mechanisms. We observed that elevated C/EBPα expression was negatively correlated with lung adenocarcinoma cell migration and invasion. We also found that C/EBPα transcriptionally suppresses the β-catenin gene, thereby constituting an important signaling pathway that directly affects EMT and invasion of lung adenocarcinoma cells. Collectively, our results strongly suggest that downregulated C/EBPα expression causes high β-catenin expression and critically contributes to lung adenocarcinoma pathogenesis and aggressive behavior.
C/EBPα has been found to exhibit tumor suppressor activity in many types of cancer [25, 26] . Bennett et al. reported that C/EBPα is epigenetically downregulated in head and neck squamous cell carcinoma [18] . Shi et al. demonstrated that overexpression of C/EBPα significantly suppressed the proliferation of primary hepatocarcinogenesis cells in vitro and reduced the growth of subcutaneous hepatocarcinogenesis xenografts in nude mice [27] . Importantly, loss of C/EBPα in mouse respiratory epithelium led to respiratory failure at birth due to an arrest in the type II alveolar cell differentiation program [15] . Lung-specific C/EBPα knockout mice developed pulmonary adenocarcinoma, suggesting that the loss of C/EBPα could be an important event in the multistep process of lung tumorigenesis [19] . In this study, we found that C/EBPα expression was significantly decreased in lung adenocarcinoma tissues compared to para-carcinoma tissues. These results are consistent with findings by Halmos et al., who found that C/EBPα expression was more frequently downregulated in adenocarcinoma compared to normal lung [16] . We also found that overexpression of C/ EBPα significantly inhibited lung adenocarcinoma cell migration and invasion ability, suggesting that C/EBPα may be an important factor affecting lung adenocarcinoma metastasis.
EMT is associated with functional changes relevant to metastasis, e.g. increased migratory and invasive abilities. During EMT, epithelial cells lose their epithelial polarity and cell-cell contacts and gain mesenchymal phenotypes with increased migratory and invasive capabilities. Accumulating evidence has shown that promoting EMT leads to tumor cell migration and invasion [28] [29] [30] . Previously, Hongbo et al. showed that enhanced C/EBPα expression successfully inhibited hepatocellular carcinoma metastasis by inhibiting EG-FR/β-catenin signaling pathway-mediated EMT in vitro and in vivo [25] , suggesting that C/
